Work

Efficacy and Safety of Deferasirox (Exjade®) in β-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.4062.4062

Authors: Dudley J. Pennell, John B. Porter, M. Domenica Cappellini, Lee Lee Chan, Amal El-Beshlawy, Yesim Aydinok, Hishamshah Ibrahim, Chi-Kong Li, Vip Viprakasit, Mohsen Saleh Elalfy, Antonis Kattamis, Gillian Smith, Dany Habr, Gabor Domokos, Bernard Roubert, Ali Taher

Institutions: Royal Brompton Hospital, University College London, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University Malaya Medical Centre, University of Malaya, Cairo University, Ege University, Hospital Kuala Lumpur, Chinese University of Hong Kong, Prince of Wales Hospital, Siriraj Hospital, Ain Shams University, National and Kapodistrian University of Athens, Novartis (Switzerland), American University of Beirut

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W575856547

FWCI: 0.604

Cites:

Cited by: 4

Related to: 10